Dublin, July 11, 2017 -- Research and Markets has announced the addition of the "Global Respiratory Care Devices Market - Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering.
The Global Respiratory Care Devices Market is estimated to witness a CAGR of 8.8% during the forecast period 2017-2023.
The factors such as rising prevalence of respiratory diseases, huge demand for enhanced portable devices, increasing geriatric population, and high prevalence of tobacco smoking are expected to drive the market growth during the forecast period. The market is witnessing the emerging trend of intelligent ventilators, portable PAP devices, smart inhalers, and nebulizers which are helping in providing real-time monitoring and transmission of data to the physicians. The markets in India, Brazil, China, and Japan are expected to grow at a rapid pace during the forecast period as the prevalence of respiratory diseases in these countries is high.
The major driver of the respiratory device market is high smoking global population, which is increasing the disease burden. Smoking causes about 90% of all lung cancer deaths and 80% of all deaths from chronic obstructive pulmonary disease (COPD). It is observed that smokers are 12-13 times more likely to die from COPD than the non-smokers. Currently, market players are developing advanced technology PAP devices for the treatment of sleep apnea. For instance, in April 2017, ResMed launched AirMini, the world's smallest CPAP machine for the treatment of sleep apnea. The PAP devices held more than half of the share of the total therapeutic respiratory care device market in 2016. A massive undiagnosed sleep apnea population is expected to provide an opportunity for the growth of the respiratory care devices market in the future.
The global respiratory care devices market by products is segmented into therapeutics, monitoring, diagnostics, and consumables. Therapeutic devices segment holds the largest share in the market with more than 65% of the total market share. Due to the better technology advancement in this segment, therapeutic devices are expected to grow at a faster CAGR during the forecast period. Among the various therapeutic devices, PAP devices are expected to grow at a high rate and occupy significant share in the market due to the huge undiagnosed population of sleep apnea. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which are defining the future of the Global Respiratory Care Devices market.
Key Players: ResMed, Medtronic Plc, Fisher and Paykel, Becton Dickenson and Company, Hamilton Medical, Drager Healthcare GmbH, Chart Industries, Philips Healthcare, Maquet (Getinge Group), Masimo Corp., GE Healthcare and other predominate & niche players.
Key Topics Covered:
1 Report Outline
2 Executive Summary
3 Market Positioning
3.1 Total Addressable Market (TAM): Medical Devices Industry
3.2 Segmented Addressable Market (SAM): Respiratory Care Devices Market
4 Market Outlook
5 Market Characteristics
6 Respiratory Devices Market by Therapeutic Areas: Market Size and Analysis
6.1 Overview
6.2 Acute Respiratory Distress Syndrome (ARDS)
6.3 Asthma
6.4 Chronic Obstructive Pulmonary Disease (COPD)
6.5 Cystic Fibrosis
6.6 Pneumonia
6.7 Sleep Apnea
6.8 Tuberculosis
7 Respiratory Care Devices Market by Product Types: Market Size and Analysis
7.1 Overview
7.2 Diagnostics Devices
7.3 Therapeutic Devices
7.4 Monitoring Devices
7.5 Consumables and Accessories
8 Respiratory Care Devices Market by End Users: Market Size and Analysis
8.1 Overview
8.2 Hospitals
8.3 Ambulatory Care Centers
8.4 Home Care
9 Respiratory Care Devices Market by Regions: Market Size and Analysis
10 Competitive Landscape
11 Vendor Profiles
11.1 Medtronic Plc
11.2 BD
11.3 Resmed Inc.
11.4 Fisher &Paykel Healthcare Ltd.
11.5 Philips Heathcare
12 Companies to Watch For
12.1 Hamlinton Medical AG
12.2 Drager Medical GmbH
12.3 Maquet Corp.
12.4 GE Healthcare
12.5 Invacare Corp.
12.6 Chart Industries Inc.
For more information about this report visit https://www.researchandmarkets.com/research/s8hjlb/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Devices


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Apple Turns 50: From Garage Startup to AI Crossroads
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 



